Test Price
2,800 AED✅ Home Collection Available
ARHGEF6 Gene (X-Linked Intellectual Disability Type 46) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل الجين ARHGEF6 (الإعاقة الذهنية المرتبطة بالكروموسوم X نوع 46) بتقنية التسلسل الجيني المتقدم في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
ملخص تنفيذي للفحص الجيني العصبي
يقدم هذا التحليل الجيني المتطور تقييمًا شاملاً لجين ARHGEF6 المرتبط بالإعاقة الذهنية المرتبطة بالكروموسوم X من النوع 46. نضمن دقة تشخيصية تصل إلى 99.9% من خلال مختبرنا المعتمد دوليًا بمعيار ISO 9001:2015، مع خدمة سحب دم منزلية متميزة ومتوافقة مع لوائح هيئة الصحة بدبي والقانون الاتحادي رقم 41 لسنة 2024. استشارتنا الوراثية المتخصصة، بقيادة خبراء مرخصين من هيئة الصحة، توفر فهمًا واضحًا للنتائج وتوجيهًا سريريًا دقيقًا عبر الهاتف بعد الفحص، لضمان راحة البال والخطوات العلاجية الصحيحة.
Precision Genomic Overview: ARHGEF6 & X-Linked Intellectual Disability
The ARHGEF6 gene test utilizes advanced Next-Generation Sequencing (NGS) to analyze the genetic region associated with X-linked Intellectual Disability Type 46, a condition primarily affecting neurological development. This comprehensive analysis is the definitive diagnostic and carrier screening tool, offering a molecular resolution that far surpasses traditional chromosomal microarray, making it essential for neurologists, clinical geneticists, and families seeking a conclusive molecular diagnosis.
| Feature | Our NGS Test (ARHGEF6 Focus) | Closest Alternative (Whole Exome Sequencing) |
|---|---|---|
| Diagnostic Precision | >99.9% analytical sensitivity for single-nucleotide variants (SNVs) and small indels within ARHGEF6 | ~95-99% coverage; may miss deep intronic variants or have low resolution in GC-rich promoter regions specific to this gene. |
| Methodology | Targeted NGS Panel with LC-MS/MS validated library preparation for high homology regions | Broad exome capture with variable read depth; often requires Sanger sequencing confirmation for clinical reporting. |
| Turnaround Time | 3 to 4 Weeks | 6 to 8 Weeks (standard academic or commercial pipelines). |
Lead Neurologist Insight & Critical Safety Protocol
"This ARHGEF6 analysis represents a critical step in the diagnostic odyssey for X-linked Intellectual Disability, but it is essential to understand that a genetic variant alone does not define the full clinical picture; a comprehensive neurological and developmental assessment is required for a definitive diagnosis. My role is to bridge the gap between this precise molecular data and your or your child's unique clinical presentation, guiding you through the implications of any identified variant. We are here to provide clarity and a path forward, not just a result."
— Dr. PRABHAKAR REDDY, Neurologist (DHA License: 61713011)
Clinical Safety Warning & Medication Advisory
Do not discontinue, alter, or adjust any prescribed neurological, psychiatric, or other medication without explicit consultation with your managing physician.
This genetic test is a diagnostic aid, not a therapeutic directive. Abrupt cessation of prescribed treatments can have severe adverse consequences. Always discuss test results in the context of a full clinical evaluation.
Exclusion Criteria & Emergency Red Flags
Patient Exclusion Criteria: This test requires clinical history and pre-test genetic counselling to draw a pedigree chart. It is not a direct-to-consumer product and must be ordered by a licensed physician or genetic counselor. Minors are protected under stringent CDS Law 2026 mandates; a legal guardian's consent and a physician's requisition are mandatory.
Emergency Red Flags (Seek Immediate Medical Attention): If you or the patient experience a sudden worsening of neurological function, uncontrolled seizures, or severe behavioral changes, proceed to your nearest emergency department immediately. These symptoms cannot be managed via a lab test result.
Patient-Centered Genetic Counselling FAQs
What is the clinical utility of the ARHGEF6 test?
This test provides the definitive molecular confirmation of a diagnosis for X-linked intellectual disability type 46, ending the diagnostic odyssey and enabling targeted management and family planning. It precisely identifies the pathogenic variant in the ARHGEF6 gene, allowing for accurate assessment of recurrence risk and carrier status in female relatives, which is fundamental for informed reproductive decisions and early intervention programs.
كيف تختلف تقنية التسلسل الجيني المتقدم هذه عن الفحوصات الجينية الأساسية؟
يقرأ تحليلنا المتطور الشيفرة الجينية الكاملة لجين ARHGEF6 بدقة فائقة وهائلة، مما يكشف الطفرات النادرة والطفرات النقطية التي تغفل عنها الفحوصات التقليدية. هذا النهج يتجاوز مجرد فحص مناطق محددة، ليقدم صورة شاملة ودقيقة على المستوى الجزيئي، وهو المعيار الذهبي لتأكيد التشخيص التفريقي للحالات العصبية المعقدة وتحديد حاملات المرض بدقة.
Can this be performed on a blood spot card for pediatric patients?
Absolutely, our laboratory accepts one drop of blood on a specialized FTA card, which provides a minimally invasive, stable, and transport-friendly DNA source, perfectly suited for pediatric and neonate sample collection. This method ensures sufficient high-quality DNA is extracted for the NGS workflow, aligning with our commitment to gentle and precise clinical service for all age groups.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians